Nicola P. Caradonna

siRNA screen identifies QPCT as a druggable target for Huntington's disease

María Jiménez-Sánchez, Wun Lam, Michael Hannus et al. · Nature Chemical Biology · 2015 · 96 citations · Full text

Life Sciences, Genetics, Molecular Biology +13

Identification of a Novel Pyrazolo[3,4-<i>d</i>]pyrimidine Able To Inhibit Cell Proliferation of a Human Osteogenic Sarcoma in Vitro and in a Xenograft Model in Mice

Fabrizio Manetti, Annalisa Santucci, Giada A. Locatelli et al. · Journal of Medicinal Chemistry · 2007 · 82 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Comparison of Cryopreserved HepaRG Cells with Cryopreserved Human Hepatocytes for Prediction of Clearance for 26 Drugs

Ugo Zanelli, Nicola P. Caradonna, David Hallifax et al. · Drug Metabolism and Disposition · 2011 · 74 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors

Serena Pasquini, Maria De Rosa, Alessia Ligresti et al. · European Journal of Medicinal Chemistry · 2012 · 24 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Structure–activity relationship and properties optimization of a series of Quinazoline-2,4-diones as inhibitors of the canonical Wnt pathway

Arianna Nencini, Carmela Pratelli, Joanna Quinn et al. · European Journal of Medicinal Chemistry · 2015 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16